Your email has been successfully added to our mailing list.

×
0 0 0 0.0341261633919338 0 -0.00255397825201341 -0.00626743129328445 -0.0118767823007741
Stock impact report

Mythic Therapeutics to Present Data from Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]

HCA Healthcare, Inc. (HCA) 
Last hca healthcare, inc. earnings: 4/21 08:30 am Check Earnings Report
US:NYSE Investor Relations: investor.hcahealthcare.com
Company Research Source: Yahoo! Finance
antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, today announced that it will present initial dose escalation results from its Phase 1 KisMET-01 study evaluating its investigational cMET-targeting ADC, MYTX-011, in patients with previously treated, locally advanced or metastatic non-small cell lung cancer (NSCLC) at the American Society of Clinical Oncology (ASCO) Annual Meeting. "We are pleased to present clinical data showcasing the potential of our lead program, MYTX-011, for patients impacted by non-small cell lung cancer," said Gilles Gallant, BPharm, Ph.D., FOPQ, Chief Development Officer at Mythic Therapeutics. "The initial dose escalation results from our ongoing KisMET-01 trial mark an important milestone in our journey, and we look forward to sharing these results with the scientific community at ASCO." Details of the presentation are as follows: Title: MYTX-011 in patients with previously treated locally advanced or metastatic NSCL Show less Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for HCA alerts
Opt-in for
HCA alerts

from News Quantified
Opt-in for
HCA alerts

from News Quantified